Unilateral Cervical Polyneuropathies following Concurrent Bortezomib, Cetuximab, and Radiotherapy for Head and Neck Cancer

We report a constellation of cervical polyneuropathies in a patient treated with concurrent bortezomib, cetuximab, and cisplatin alongside intensity modulated radiotherapy for carcinoma of the tonsil with neck metastasis. The described deficits include brachial plexopathy, cervical sensory neuropath...

Full description

Saved in:
Bibliographic Details
Main Authors: Alhasan Elghouche, Tom Shokri, Yewen Qin, Susannah Wargo, Deborah Citrin, Carter Van Waes
Format: Article
Language:English
Published: Wiley 2016-01-01
Series:Case Reports in Otolaryngology
Online Access:http://dx.doi.org/10.1155/2016/2313714
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849402258153799680
author Alhasan Elghouche
Tom Shokri
Yewen Qin
Susannah Wargo
Deborah Citrin
Carter Van Waes
author_facet Alhasan Elghouche
Tom Shokri
Yewen Qin
Susannah Wargo
Deborah Citrin
Carter Van Waes
author_sort Alhasan Elghouche
collection DOAJ
description We report a constellation of cervical polyneuropathies in a patient treated with concurrent bortezomib, cetuximab, and cisplatin alongside intensity modulated radiotherapy for carcinoma of the tonsil with neck metastasis. The described deficits include brachial plexopathy, cervical sensory neuropathy, and oculosympathetic, recurrent laryngeal, and phrenic nerve palsies within the ipsilateral radiation field. Radiation neuropathy involving the brachial plexus is typically associated with treatment of breast or lung cancer; however, increased awareness of this entity in the context of investigational agents with potential neuropathic effects in head and neck cancer has recently emerged. With this report, we highlight radiation neuropathy in the setting of investigational therapy for head and neck cancer, particularly since these sequelae may present years after therapy and entail significant and often irreversible morbidity.
format Article
id doaj-art-8b2d4bf9710543dfb5e65a9f13b522de
institution Kabale University
issn 2090-6765
2090-6773
language English
publishDate 2016-01-01
publisher Wiley
record_format Article
series Case Reports in Otolaryngology
spelling doaj-art-8b2d4bf9710543dfb5e65a9f13b522de2025-08-20T03:37:34ZengWileyCase Reports in Otolaryngology2090-67652090-67732016-01-01201610.1155/2016/23137142313714Unilateral Cervical Polyneuropathies following Concurrent Bortezomib, Cetuximab, and Radiotherapy for Head and Neck CancerAlhasan Elghouche0Tom Shokri1Yewen Qin2Susannah Wargo3Deborah Citrin4Carter Van Waes5Indiana University School of Medicine, 1120 W. Michigan Street, Suite 200, Indianapolis, IN 46202, USADivision of Otolaryngology, Penn State Milton S. Hershey Medical Center, 100 Campus Drive, Suite 400, Hershey, PA 17033, USAKing’s College London School of Medicine, Strand, London WC2R 2LS, UKHead and Neck Surgery Branch, National Institute on Deafness and Other Communication Disorders, 9000 Rockville Pike, Bethesda, MD 20892, USARadiation Oncology Branch, Center for Cancer Research, National Cancer Institute, 9000 Rockville Pike, Bethesda, MD 20892, USAHead and Neck Surgery Branch, National Institute on Deafness and Other Communication Disorders, 9000 Rockville Pike, Bethesda, MD 20892, USAWe report a constellation of cervical polyneuropathies in a patient treated with concurrent bortezomib, cetuximab, and cisplatin alongside intensity modulated radiotherapy for carcinoma of the tonsil with neck metastasis. The described deficits include brachial plexopathy, cervical sensory neuropathy, and oculosympathetic, recurrent laryngeal, and phrenic nerve palsies within the ipsilateral radiation field. Radiation neuropathy involving the brachial plexus is typically associated with treatment of breast or lung cancer; however, increased awareness of this entity in the context of investigational agents with potential neuropathic effects in head and neck cancer has recently emerged. With this report, we highlight radiation neuropathy in the setting of investigational therapy for head and neck cancer, particularly since these sequelae may present years after therapy and entail significant and often irreversible morbidity.http://dx.doi.org/10.1155/2016/2313714
spellingShingle Alhasan Elghouche
Tom Shokri
Yewen Qin
Susannah Wargo
Deborah Citrin
Carter Van Waes
Unilateral Cervical Polyneuropathies following Concurrent Bortezomib, Cetuximab, and Radiotherapy for Head and Neck Cancer
Case Reports in Otolaryngology
title Unilateral Cervical Polyneuropathies following Concurrent Bortezomib, Cetuximab, and Radiotherapy for Head and Neck Cancer
title_full Unilateral Cervical Polyneuropathies following Concurrent Bortezomib, Cetuximab, and Radiotherapy for Head and Neck Cancer
title_fullStr Unilateral Cervical Polyneuropathies following Concurrent Bortezomib, Cetuximab, and Radiotherapy for Head and Neck Cancer
title_full_unstemmed Unilateral Cervical Polyneuropathies following Concurrent Bortezomib, Cetuximab, and Radiotherapy for Head and Neck Cancer
title_short Unilateral Cervical Polyneuropathies following Concurrent Bortezomib, Cetuximab, and Radiotherapy for Head and Neck Cancer
title_sort unilateral cervical polyneuropathies following concurrent bortezomib cetuximab and radiotherapy for head and neck cancer
url http://dx.doi.org/10.1155/2016/2313714
work_keys_str_mv AT alhasanelghouche unilateralcervicalpolyneuropathiesfollowingconcurrentbortezomibcetuximabandradiotherapyforheadandneckcancer
AT tomshokri unilateralcervicalpolyneuropathiesfollowingconcurrentbortezomibcetuximabandradiotherapyforheadandneckcancer
AT yewenqin unilateralcervicalpolyneuropathiesfollowingconcurrentbortezomibcetuximabandradiotherapyforheadandneckcancer
AT susannahwargo unilateralcervicalpolyneuropathiesfollowingconcurrentbortezomibcetuximabandradiotherapyforheadandneckcancer
AT deborahcitrin unilateralcervicalpolyneuropathiesfollowingconcurrentbortezomibcetuximabandradiotherapyforheadandneckcancer
AT cartervanwaes unilateralcervicalpolyneuropathiesfollowingconcurrentbortezomibcetuximabandradiotherapyforheadandneckcancer